About Genovis

Genovis is a biotechnology company providing products for medical research. The company supplies technology, products and support that ease the efforts of companies conducting pharmaceutical development and preclinical research. The technology emanating from NIMT® (NanoInduced Magnetic Transfer) is both a methodology as well as a technical tool that includes nanoparticles and laboratory instruments.


Genovis shares are traded on First North, which is a part of the OMX Nordic Exchange.